We examined the potential role of fibroblast growth factor 5 (FGF-5) as a target-derived trophic factor for spinal motoneurons. Northern analysis of total RNA from rat skeletal muscle revealed an FGF-5 mRNA transcript both during the period of embryonic motoneuron death and in the adult. Recombinant human FGF-5 supported the survival of highly enriched cultures of embryonic chick motoneurons. Significant proportions of the motoneuron survival activity of rat skeletal muscle extracts could be immunoprecipitated using an antiserum to FGF-5. The immunoprecipitable activity was present in soluble and matrix-bound forms in embryonic muscle, but bound exclusively to the extracellular matrix in adult muscle. These results, along with the secretory nature of FGF-5, suggest that FGF-5 may act as a target-derived trophic factor for motoneurons.
Introduction
During the course of embryonic development, many neuronal populations undergo a period of naturally occurring cell death. In the vertebrate, the survival of neurons during this period has been demonstrated in several instances to be dependent upon access of the developing neurons to specific trophic factors supplied by target tissues (for review, see Oppenheim, 1991) . For example, nerve growth factor (NGF) is known to be produced in limiting amounts in the target tissues of peripheral sympathetic and sensory neurons, and considerable evidence has been accumulated demonstrating that NGF supports the survival of these cells during critical stages of development (for review, see Barde, 1989) . Similarly, motoneurons have been shown to rely upon their target during the embryonic period of naturally occurring cell death (Hamburger, 1958; Hollyday and Hamburger, 1976) . In addition, a number of groups have described the ability of extracts of skeletal muscle, the target of motoneurons, to promote the survival of motoneurons in culture (Bennett et al., 1980; Schnaar and Schaffner, 1981; Calof and Reichardt, 1984; Kaufman et al., 1985; Flanigan et al., 1985; Smith et al., 1985; Dohrmann et al., 1986; O'Brien and Fischbach, 1986; Martinou et al., 1989; Arakawa et al., 1990; Bloch-Gallego et al., 1991; Jeong et al., 1991) . However, attempts to determine the molecular nature of the factor(s) involved in regulating motoneuron survival during development have been largely unfruitful.
We have previously demonstrated that several neurotrophic and growth factors support the survival of spinal motoneurons in highly enriched cultures taken horn embryonic day 6 (E6) chick (Arakawa et al., 1990) . The best of these, ciliary neurotrophic factor (CNTF) and basic fibroblast growth factor (bFGF), support the survival of approximately 60% and 50%, respectively, of the initially plated motoneurons after 3 days in culture. In combination, CNTF and bFGF give 100% motoneuron survival under the in vitro conditions employed. Furthermore, exogenously applied recombinant CNTF is able to prevent the otherwise extensive motoneuron degeneration seen after lesion of the facial nerve of the newborn rat as well as rescue a significant number of spinal motoneurons that would otherwise undergo naturally occurring cell death in the embryonic chick (Oppenheim et al., 1991) . However, neither CNTF nor bFGF is likely to be responsible for the physiological regulation of embryonic neuronal survival, since both CNTF and bFGF are apparently cytosolic molecules (Ab raham et al., 1986; Lin et al., 1989; Stockli et al., 1989) and CNTF mRNA cannot be detected in skeletal muscle during the period of embryonic motoneuron death in the rat (Stockli et al., 1991) .
To meet the requirements expected of a neurotrophiC factor capable of regulating motoneuron survival during the embryonic period of cell death, a putative candidate molecule should support motoneuron survival and be appropriately expressed in target tissues. We have examined a member of the FGF family, FGF-5, for its ability to fulfill these criteria. FGF-5 was originally described as the product of a human oncogene (Zhan et al., 1987) and upon cloning was found to belong to the FGF family (Zhan et al., 1988) . FGF-5 consists of 268 amino acids and appears to be moderately well conserved across mammals; the murine homolog shows 84% overall amino acid identity with the human form (Hebert et al., 1990) . Unlike the prototypical FGFs, acidic FGF (aFGF) and bFGF. FGF-5 contains a hydrophobic N-terminal leader sequence typical of a secreted protein (Zhan et al., 1988) and is released into the medium of transformed NIH 3T3 cells . mRNA for FGF-5 can be found prior to gastrulation in mouse embryos, suggesting that this factor may have an important function during very early stages of embryonic development (Hebert et al., 1991; Haub and Goldfarb, 1991) . We demonstrate here that recombinant human FGF-5 is able to support the survival of chick spinal motoneurons in culture and that both FGF-5 50 mRNA and immunoprecipitable activity are present in embryonic rat skeletal muscle during the period of naturally occurring motoneuron death as well as in adult muscle. The data indicate that FGF-5 b a major survival factor present in skeletal muscle for cultured spinal motoneurons and, taken together with the secretory nature of FGF-5, are consistent with a potential role for this protein in the maintenance of motoneuron survival during development and adulthood.
Results
The mRNA for FGF-5 Is Expressed in Rat Skeletal Muscle during Embryonic Development and in the Adult To determine whether FGF-5 mRNA is expressed in the target tissue of motoneurons either during embryonicdevelopment or in adulthood, we performed Northern blot analysis of total RNA obtained from hindlimb skeletal muscle of embryonic (E15 and El7), newborn, and adult rats. Following high stringency washing, a cRNA probe from mouse FGF-5 was found to hybridize specifically to a band migrating marginally faster than the 18S band (approximately 1.7 kb) in rat skeletal muscle RNA at all time points studied ( Figure la) . The FGF-5-specific transcript observed in muscle is similar in size to the major FGF-5 transcript seen in Northern blots of polyadenylated RNA obtained from cultured human fibroblasts (Werner et aI., 1991) . The probe also hybridizes to a band of identical size in adult rat hippocampus (Figure lb) , a known site of FGF-5 expression in the mouse (Haub et aI., 1990) . Results are means ± 1 standard deviation from a minimum of four cultures irom at least two independent experiments. Open circles. no added heparin; closed circles. 500 ng/ml heparin.
FGF-5 Supports the Survival of E6 Chick Spinal Motoneurons in Culture
The ability of recombinant human FGF-5 to support the survival of E6 chick motoneurons in vitro was determined in the absence and presence of heparin (Figure 2) . Alone, FGF-5 supports the survival of a maximum of 27% of the initially plated motoneurons at a concentration of 10 ng/ml after 72 hr in culture. In the presence of heparin sulphate (500 ng/ml), the survival effect of FGF-5 is increased significantly, such that 45% of plated motoneurons are supported at a concentration of 100 ng/ml. Motoneurons cultured in the presence of the same concentration of heparin alone did not exhibit Significantly better survival behavior than control cultures (9% survival after 3 days). The concentration of FGF-5 required to give half-maximal survival of motoneurons is 800 pg/ml. Thus, in cultures of E6 chick spinal motoneurons, FGF-5 is less effective in promoting neuronal survival than either bFGF or CNTF (maximally 50% and 61 % survival, respectively, after 3 days in culture), but significantly better than other heparin-dependent members of the FGF family tested, such as aFGF and hst/K-FGF (maximally 36% and 32% survival, respectively, after 3 days in culture; Figure 3 ). Furthermore, combination of FGF-5 with either CNTF or bFGF at supramaximal concentrations in the presence of heparin (500nglml) gave an additive effect on motoneuron survival, such that FGF-5 and CNTF or FGF-5 and bFGF supported approximately 74% and 80%, respectively, of the originally plated motoneurons after 3 days in culture (Figure 3 ). Similarly to CNTF and bFGF, FGF-5 supported the survival of cultured E8 chick ciliary ganglion neurons (data not shown). 
A Significant Proportion of the Survival Activity of Extracts of Embryonic Skeletal Muscle Can Be Precipitated with an Anti-FGF-5 Peptide Antiserum
To investigate the contribution, if any, of FGF-S to the motoneuron survival activity of embryonic and adult rat skeletal muscle extracts, we performed immunoprecipitation experiments with an antiserum to FGF-S. The antiserum was raised in rabbits against a synthetic peptide representing a sequence from near the C-terminus of human FGF-5. The sequence was judged by hydropathy analysis (Hoppand Woods, 1981; Kyte and Doolittle, 1982) to be relatively hydrophilic and therefore likely to be exposed on the surface of intact FGF-S. Furthermore, the peptide spans a region of the C-terminal "tail" of FGF-5, which, although well conserved between species, is not present in the other known members of the FGF family; this fact reduces the likelihood that the resultant antiserum would cross-react with other FGFs. Although the antiserum raised against this peptide did not recognize recombinant human FGF-5 on immunoblots (data not shown), it was possible to precipitate the motoneuron survival activity of recombinant human FGF-5 almost entirely using the antiserum (Figure 4 ),.consistent with an ability of this antiserum to recognize native FGF-5 in solution. In contrast, the antiserum was unable to immunoprecipitate the motoneuron survival activity of either any other member of the FGF family tested (aFGF, bFGF, and hst/K-FGF) or CNTF. Figure 5 shows the motoneuron survival activity of an extract of phosphate-buffered saline (PBS)-soluble components of E17 rat skeletal muscle before (column B) and after (column C) the addition of anti-FGF-S antiserum bound to protein G-Sepharose. Following centrifugation of the antiserum-Sepharose complex, the survival activity of the soluble embryonic muscle extract on E6 chick spinal motoneurons at the maximum protein concentration tested (250 I!g/ml) was reduced from 60% to 36% after 3 days in culture. This represents a 47% reduction in survival activity, given the background survival of 9% in control cultures ( Figure  S , column A). The result suggests that a significant proportion of the survival activity of the PBS-soluble components of E17 rat skeletal muscle may be due to FGF-5.
Members of the FGF family, including FGF-5, have a propensity to bind to components of the extracellular matrix. We thus attempted to determine whether additional, matrix-bound, FGF-5-like motoneuron survival activity that could not be extracted with PBS alone is present in embryonic rat skeletal muscle. The pellets obtained after PBS extraction of E17 muscle were reextracted with PBS containing 3 M NaCl and 10 mM EOT A. These conditions would be expected to disrupt interactions between the extracellular matrix and molecules bound to it and thus allow solubilization of matrix-bound components. The high molar salt extract of E17 muscle exhibited a maximal survival effect on cultured chick spinal motoneurons which was less than that observed with the soluble extract (approximately 37% survival after 3 days in culture; Figure 5 , column El. although this effect was achieved at lower total protein concentrations (60 I!g/ml). Immunoprecipitation of this extract with anti-FGF-5 antiserum led to an 83% reduction in the maximal motoneuron survival of the extract ( Figure 5 , column n. Thus, approximately 65% of the total (PBS and high molar salt) maximal motoneuron survival activity extractable from E17 rat skeletal muscle can be immunoprecipitated by anti-FGF-5 antiserum, and approximately one-half of this activity is apparently quite tightly bound to the matrix. Control precipitation of either the soluble or matrix-bound extract of embryonic muscle with anti-CNTF antiserum did not lead to a significant reduction in the motoneuron survival activity of either of these extracts ( Figure 5 , columns D and G). Reextraction of the muscle pellets with PBS alone failed to solubilize significant amounts of either total protein or motoneuron survival activity (data not shown).
Immunoprecipitation of Adult Muscle Extracts with Anti-FGF-S Antiserum Suggests That FGF-S Protein Is Almost Entirely Matrix Bound
To determine whether FGF-5 might also be a component of adult rat skeletal muscle extracts, attempts were made to precipitate motoneuron survival activity from adult muscle extracts with anti-FGF-5 antiserum linked to protein G-Sepharose. PBS-soluble extracts of adult skeletal muscle exhibited maximal motoneuron survival activity of approximately 37% at a protein concentration of 125 J-lg/ml after 3 days in culture (Figure 6, column B) . However, unlike the PBS-soluble embryonic muscle extract, none of the activity of the soluble extract of adult rat skeletal muscle could be precipitated with anti-FGF-5 antiserum ( Figure 6 , column Cl. Conversely, a major proportion (71 %) of the maximal survival activity of the high molar salt extract of adult rat skeletal muscle extract (33% at 7 J-lg/ml protein) could be precipitated with anti-FGF-S antiserum ( Figure 6 , columns E and F). The fact that FGF-5 immunoprecipitable activity could not be extracted from adult rat skeletal muscle with PBS and required harsher extraction conditions of high salt and EDTA to facilitate its solubilization, suggests that FGF-5 in adult rat muscle is almost exclusively tightly bound to the extracellular matrix. Small proportions of both the PBS-soluble and high molar salt-EDTA extracts of adult muscle (approximately 30% and 29%, respectively) were amenable to immunoprecipitation with anti-CNTF antiserum ( Figure 6 , columns D and G).
Discussion
The motoneu ron survival activity obtainable from embryonic and adult rat skeletal muscle could be broadly divided into two categories: that readily extractable with PBS and that requiring high molar salt and EDTA to effect solubilization. Of the four types of muscle extract prepared, the PBS-soluble extract of E17 muscle gave the greatest maximal survival effect on cultured chick motoneurons (60% after 3 days in culture). The other embryonic and two adult extracts exhibited significantly lower yet similar maximal survival effects (approximately 36%), although the maximal effects of the soluble and matrix-bound adult extracts may have been reduced by the presence of toxic components in these extracts. The high maximal survival activity extractable from embryonic compared with adult skeletal muscle may reflect a greater reliance of developing embryonic motoneurons on trophic support during the period of naturally occurring motoneuron death or the production by adult muscle of a "neurotrophic cocktail" not optimally suited to the survival of embryonic neurons. Interestingly, high salt-EDTA extraction of embryonic and adult skeletal muscle afforded extracts with apparent specific activities relative to total protein content that were approximately 4-and 17-fold greater, respectively, than their PBSsoluble counterparts. Thus, compared with soluble proteins, a larger proportion of matrix-bound proteins in muscle exhibit motoneuron survival activity.
Immunoprecipitation experiments with a specific antiserum to FGF-5 were used to ascertain what percentage, if any, of the motoneuron survival activity of the embryonic and adult muscle extracts might be attributable to FGF-5. From hindlimb skeletal muscle prepared from E17 rats, at which age the period of naturally occurring embryonic motoneuron death is underway (Oppenheim, 1986) , approximately 60% of the total maximal extractable survival activity could be immunoprecipitated by the anti-FGF-5 antiserum. The FGF-5 immunoprecipitable activity in E17 muscle was distributed between a PBS-soluble form and a less readily extracted species, the latter requiring high molar salt and EDTA for extraction. In contrast, FGF-5 activity in adult skeletal muscle was found to exist exclusively in the latter, matrix-bound form. FGF-5, like the other members of the FGF family, exhibits strong binding to the glycosaminoglycan heparin (Zhan et al., 1988) and thus would be expected to associate tightly to heparan sulphate-like components of the extracellular matrix. Thus, the apparent lesser solubility of the FGF-5 immunoprecipitable activity from adult rat skeletal muscle compared with that of the embryo probably reflects a difference in the nature or composition of the extracellular matrix in the adult animal. Similar developmental changes have previously been noted in the case of extractability of other components of the extracellular matrix, such as laminin (Kucherer-Ehret et al., 1990 ).
An antiserum to a 27 amino acid peptide from CNTF (StOckli et al., 1991) was favored over preimmune serum as a control serum for the immunoprecipitation experiments. The anti-CNTF antiserum was unable to precipitate the motoneuron survival activity of either recombinant FGF-5 or embryoniC muscle extracts; the latter finding is in concordance with the observations that CNTF mRNA in the rat is below detectable limits during the period of naturally occurring motoneuron death (Stockli et al., 1989 (Stockli et al., , 1991 . These results allowed us to disregard with confidence the interpretation that reductions in motoneuron survival activity observed following precipitation with the anti-FGF-5 antiserum might be due to nonspecific binding of a neurotrophic factor(s) to the generally increased IgG levels expected in immunized animals. A small yet significant reduction in the survival activity of adult muscle extracts could be brought about by immunoprecipitation with the anti-CNTF antiserum. This phenomenon is probably the result of the presence of CNTF in nerves innervating adult muscle. Indeed, CNTF immunoreactivity is clearly detectable in Schwann cells surrounding nerves in sections of adult skeletal muscle (B. Holtmann and M. Sendtner, unpublished data). Furthermore, extracts of adult rat skeletal muscle that has been surgically denervated for 7 days, during which time nerve fibers and their accompanying Schwann cells distal to the lesion site would be expected to degenerate, no longer exhibit anti-CNTF immunoprecipitable motoneuron survival activity (R. A. Hughes and M. Sendtner, unpublished data).
FGF-5 immunoprecipitable activity in E17 skeletal muscle extracts could originate from two sources, the muscle itself (as the observed expression of FGF-5 mRNA in this tissue would attest) and/or a site of earlier expression. Indeed, the most prominent embryonic expression of FGF-5 mRNA beyond gastrulation in the mouse occurs at E12.5-E14.5 in a patch of mesenchyme at the base of the hindlimb (Haub and Goldfarb, 1991) . It may be that FGF-5 protein similarly expressed in the developing rat is deposited in the surrounding muscle and thus contributes to the observed FGF-5-like activity in E17 muscle extracts. The expression of FGF-5 mRNA in adult rat muscle is consistent with the hypotheSiS that the major source of FGF-5 in this tissue is the muscle itself. The previously reported absence of FGF-5 mRNA in Northern blots of RNA from adult mouse skeletal muscle suggests either that the FGF-5 gene is regulated differently in these two species, or that the amounts of FGF-5 mRNA in mouse were below detectable limits. Our investigations do not formally exclude the possibility that the FGF-5-like activity observed in skeletal muscle might be supplied in part by nerve fibers present within the muscle. However, the apparent contribution of CNTF to the survival activity of adult muscle extracts is small, indicating that the contamination of these extracts with nerve fibers is minor. Thus, unless sciatic nerve proves to be an exceptionally rich source of FGF-5, it is unlikely that the FGF-5-like activity observed !n muscle extracts is derived to a significant extent from nervous tissue.
A family of membrane-spanning protein tyrosine kinases, encoded by at least four distinct genes, are capable of acting as signal-transducing units for the FGFs (Ruta et al., 1988; Kornbluth et al., 1988; Lee et al., 1989; Dionne et al., 1990; Pasquale, 1990; Miki et al., 1991; Keegan et al., 1991; Partanen et al., 1991; Stark et al., 1991) . These tyrosine kinases exist in a variety of molecular forms generated by alternative RNA splicing Oohnson et al., 1990 Oohnson et al., , 1991 and bind different members of the FGF family with differing affinities (Johnson et al., 1991; Miki et al., 1991; Partanen et al., 1991) . The binding of FGFs to the receptor tyrosine kinases requires the participation of heparan sulphate proteoglycan or soluble heparin (for review, see Klagsbrun and Baird, 1991) . Recombinant human FGF-5 is able to bind and activate FGF receptors 1 and 2. The relative affinities of FGF-5 and bFGF for these receptors (D. Clements, J.-K. Wang, C. Dionne, and M. Goldfarb, unpublished data) correlate with the relative concentrations of these factors required to support chick motoneurons in culture. This would suggest that the expression of FGF receptor 1 or 2 in embryonic motoneurons partially accounts for FGF survival effects. Indeed, mRNA for FGF receptor 1 has been detected in motolleurons of newborn and adult rats using in situ hybridization techniques (Wanaka et al., 1990 (Wanaka et al., ,1991 . Given the enhanced survival of chick motoneurons cultured in the presence of a combination FGF-5 and bFGF, it is possible that at least three distinct FGF receptors mediate survival of chick motoneurons in vitro: one receptor with specificity for FGF-5, one for bFGF, and a third (perhaps FGF receptor 1 or 2) able to respond to both ligands.
The molecular nature of the motoneuron survival activity present in embryonic and adult skeletal muscle extracts that could not be immunoprecipitated by anti-FGF-5 antiserum remains undetermined. The presence of other FGF-related molecules in skeletal muscle of several species is relatively well documented, even though the exact molecular entity under question has not always been precisely defined. Using immunohistochemical techniques, bFGF-like immunoreactivity has been detected in developing skeletal muscle of embryonic chick (Joseph-Silverstein et al., 1989) , rat (Gonzalez et al., 1990) , and rabbit (Morrow et al., 1990) , and a molecule with bFGF-like characteristics has been detected in human embryonic and adult skeletal muscle (Vaca et al., 1989) . In a similar manner, polyclonal antisera to aFGF have been used to demonstrate the presence of this molecule in embryonic rat skeletal muscle (Fu et al., 1991) , and mRNA for aFGF has been detected by Northern blot analysis of total RNA obtained from embryonic cattle muscle (Alterio et al., 1990) . Nonetheless, the absence of demonstrable secretion of aFGF and bFGF makes it difficult to reconcile how either of these factors might be made available to act as a target-derived neurotrophic factor for motoneu rons.
A number of other candidate target-derived trophic factors for developing spinal motoneurons have previously been proposed. One of these, choline acetyltransferase development factor (CDF), has been purified from rat skeletal muscle and shown to increase levels of choline acetyltransferase activity in embryonic rat spinal cord cultures (McManaman et al., 1988 (McManaman et al., , 1989 . Although conclusive survival effects of CDF on highly enriched or purified motoneuron cultures have yet to be demonstrated, CDF does share a number of properties with FGF-5, including apparent abundance in skeletal muscle and effects that are additive with bFGF (McManaman et al., 1989; McManaman and Crawford, 1991) . Nonetheless, several differences between CDF and FGF-5, such as extent of glycosylation and heparin binding characteristics, suggest that they are distinct entities. Identification ,of the exact molecular nature of CDF awaits the cloning of this factor.
A cholinergiC differentiation factor for sympathetic neurons originally isolated from heart muscle-conditioned medium (Fukada, 1985) was found upon cloning (Yamamori et al., 1989) to be identical to leukemia inhibitory factor (LlF). LlF exhibits a degree of functional overlap with CNTF (for review, see Patterson, 1992) , including a survival effect on cultured rat motoneurons (Martinou et al., 1992) . It has recently been reported that LlF mRNA, unlike CNTF message, is present in low amounts in embryonic rat skeletal muscle (Patterson and Fann, 1992) . However, it has been shown that murine LlF is unable to act on other chick cells in culture even at high concentrations (Rohrer, 1992) . presumably as a result of species differences. Thus, LlF would not be expected to contribute to the motoneu ron survival activity of the rat muscle extracts observed in the cultures described here. The extent to which LlF produced in rat skeletal muscle might promote motoneuron survival and function remains a matter of conjecture.
The data presented here demonstrate that FGF-S is a major skeletal muscle-derived survival factor for cultured spinal motoneurons. Furthermore, the expression of FGF-S in muscle and its secretory nature are compatible with the hypothesis that this protein may provide target-derived trophic support to motoneurons both during embryonic development and in adulthood. Other experimental systems could be used to clarify whether FGF-S indeed plays a role in regulating motoneuron survival in vivo, or perhaps partakes in the modulation of other motoneuronrelated functions, such as transmitter synthesis or synapse formation. These systems include the in vivo administration of blocking FGF-S antibodies during development, and the gene knockout or tissue-specific overexpression of FGF-5 in transgenic animals.
Experimental Procedures
Materials . Recombinant human FGF·5 was purified from the soluble fraction of Escherichiacoli Iysates by heparin-Sepharose chromatography and Mono S fast protein liquid chromatography (D. elements, ).-K. Wang, C. Dionne, and M. Goldfarb, submitted). Recombinant rat CNTF was prepared from transfected E. coli using a modification of the method described by Masiakowski et al. (1991) , in which the chromatographic purification of the protein on DEAE-cellulose was replaced by a single reversephase, high pressure liquid chromatography step on a semipreparative, butyl column (Baker). Recombinant human K-FGF was generously provided by C Basilico, NY_ Recombinant aFGF and bFGF were kind gifts from W. Risau, Martinsried, Germany. N-fluorenylmethoxycarbonyl (Fmoc) amino acid derivatives, 2-(1 H-benzotriazol-l-yll-l,l,3,3-tetramethylu ron ium hexafl uorophospate (HBTU), HMP resin, solvents, and miscellaneous reagents for peptide synthesis were from Applied Biosystems, Weiterstadt, Germany; Freund's complete and incomplete adjuvants and leibovitz's l-15 medium, from GIBCO BRl, Eggenstein, Germany; metrizamide, from Serva, Heidelberg, Germany; protein G-Sepharose solution, from Pharmacia, Freiburg, Germany; general laboratory reagents, from Sigma Chemie, Deisenhofen, Germany, and E. Merck, Darmstadt, Germany.
Northern Blots Hindlimb skeletal muscle was dissected from embryonic (E15 and El7), newborn, and adult rats killed by ether overdose. Particular care was taken to exclude bone, cartilage, a nd skin, and total RNA was extracted from the muscle according to the method 01 Chomczynski and Sacchi (1987) . RNA samples thus obtained were glyoxylated, electrophoresed through a 1.4% agarose gel (lindholm et aI., 1988) , and vacuum blotted to nylon membranes (Hybond-N, Amersham, Braunschweig, Germany). The membranes were hybridized overnight in 50% formamide as described (Castren et aI., 1992 ) with a 500 bp cRNA probe to FGF-S. The probe (specific activity 10" cpm/Ilg) wa~ made by run-on transcription of a pBluescript SK+ vector containing a 2.2 kb mouse Fgf-S cDNA fragment (Haub and Goldfarb, 1991) linear· ized with BglIl.
Antiserum Preparation
The nonadecapeptide CFKQSEQPElSF1V1VPEK containing a relatively hydroph ilic 18 amino acid sequence from near the C-terminus of human FGF-5 (Phe-217 to lys-234), which is highly conserved between species (human-mouse amino acid identity at 100%; Haub et aI., 1990) but bears no sequence homology With other members of the FGF family, was synthesized on an Applied Biosystems 431A automated peptide synthesizer using N-Fmoc amino acid derivatives and HBTU-assisted coupling steps. Following deprotection and cleavage from the resin, the crude peptide free acid was purified as required by reverse-phase, high pressure liquid chromatography from 0.1% trifluoroacetic acid on a butyl column using an acetonitrile gradient (0%-70% acetonitrile in 30 min). New Zealand rabbits were immunized by intracutaneous injection into at least four sites on the back with 700 Ilg of the above-described peptide dissolved in 500 III of H 20 and emulsified with an equal volume of Freund's complete adjuvant. Rabbits were boosted with a similar quantity of peptide solution emulsified with Freund's incomplete adjuvant at 3-4 weekly intervals. Blood samples were removed 1 week after boosting by severing an ear vein, allowed to coagulate (37°C for 2 hr then overnight at 4°C), and centrifuged (6000 x g, 25 min). The resultant serum was sterile filtered (0.2 Ilm) and used in immunoprecipitation assays.
Motoneuron Cultures
Chick spinal motoneuron cultures were prepared as previously described (Arakawa et aI., 1990 )_ Briefly, lateral motor columns were dissected from the lumbar region of six E6 chick spinal cords, trypsinized, and triturated. The resultant cell suspension was filtered and centrifuged through a bed of6.8% metrizamide. Cells from the interface were collected, and the suspension was concentrated by centrifugation, resuspended in CO,-buffered l-15 medium supplemented with horse serum (10%), and plated in four well culture dishes (C A. Greiner und Sohne GmbH, Nurtingen, Germany) at a concentration of 1000-2000 cells per well. The wells had been previously coated with poly-mornithine and laminin (the latter solu.;.)n was removed just prior to plating). The cells were incubated at 37°C in a humidified incubator in an atmosphere of 5% CO, for 1 hr, factors and/or extracts were added at the appropriate concent rations, and cells were returned to the incubator for the length of the experiment. The culture medium and factors were renewed after 24 hr. large (~14 Ilm in diameter), phase-bright cells were counted 72 hr after plating, unless otherwise specified, in predetermined areas corresponding to 23% of each well bottom.
Preparation of Skeletal Muscle Extracts
Hindlimb skeletal muscle was dissected from embryonic (El7) and adult rats as described above. Extracts of soluble skeletal muscle proteins were obtained by homogenizing the muscle on ice in 2-3 volumes of PBS in a glass-glass homogenizer and centrifuging (100,000 x g, 4°C, 30 min). Matrix-bound components were obtained by reextraction of the pellets obtained abol/e with 2-3 initial muscle volumes of PBS supplemented with NaCI (3 M) and EDTA (10 mM) and centrifugation as for soluble extracts. The protein concentration of the resultant extracts was determined by the method of Bradford (1976) using bovine serum albumin as a standard. The skeletal muscle extracts were stored at -70°C until use.
Immunopredpitation Experiments Thirty microliters of protein G-Sepharose Fast Flow suspension was centrifuged (14,000 rpm,S mini, and the Sepharose was resuspended in 150 ~I of 0.5 x Tris-butfered saline (pH 7.4). To this suspension was added 200 ~I of either anti-FGF-5 peptide antiserum prepared as described above or control antiserum raised against a 27 amino acid peptide from CNTF (antiserum I; Stockli et aI., 1991) . The mixture was incubated for 1 hr at room temperature on an inverting mixer. The protein G-Sepharose antiserum complex was washed three times with 500 III of Trisbuffered saline, after which 20 ~I of 0.5 x TBS and either 60 ~I of muscle extract (5 Ilg/~i) or 60 ~I of recombinant human FGF-5 solution 11 ng/~1 in L-15(CO,)) medium supplemented with 10% horse serum) were added. Following centrifugation. the resultant supernatants were added to motoneuron cultures.
